US Patent Issued to ENTOS PHARMACEUTICALS on Oct. 28 for "Recombinant polypeptides for membrane fusion and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,557, issued on Oct. 28, was assigned to ENTOS PHARMACEUTICALS INC. (Edmonton, Canada).

"Recombinant polypeptides for membrane fusion and uses thereof" was invented by Roy Duncan (Mineville, Canada), Eileen Kathryn Clancy (San Francisco), John Lewis (London, Canada), Roberto Justo De Antueno (Halifax, Canada) and Rae-Lynn Nesbitt (Port Stanley, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a recombinant polypeptide for facilitating membrane fusion. The recombinant polypeptide having a sequence with at least 80% sequence identity with the ectodomain of p14 fusion-associated small transmembrane (FAST) protein and having a functiona...